Nikhil Reddy Podduturi - Digital Foundations For Rapid Healthcare Advancement (FODD #12)

In this talk, Murat speaks with ⁠Nikhil Podduturi⁠, Head of Data Science at the Digital Lab of ⁠Boehringer Ingelheim⁠ - ⁠(BI X)⁠.  

Nikhil co-leads the laboratory and data science chapters at the BI X headquarters in Germany and China. The team at BI X is pioneering digital innovations to improve the lives of patients and animals. The current technologies developed by BI X include PetPro Connect, Farmera, and Pathological Speech Processing, with impacts spanning multiple healthcare fields. 

Nikhil's current work involves developing new tools to accelerate drug discovery with advanced genetic sequencing technologies, designing new in silico systems to identify indications for drugs, as well as incorporating AI and ML technologies across BI X's digital health platforms. 

You will learn:

How the BI X team was founded. How BI X is using a data-driven approach to advance drug discovery and healthcare.    Regulatory steps involved in approving a digital health product. Future directions for BI X. How to get involved.

Things mentioned:

Center for Computational Biology and Bioinformatics at Columbia Mike Schmelmer Alibaba Oxford Nanopore SAMD - Software as a Medical Device ISO - International Organization for Standardisation ESMFold: Read here UK Biobank

Additional Materials: 

⁠⁠⁠⁠⁠⁠⁠Watch the recording of the live event! https://youtu.be/5l69jvIu5DQ

First time hearing about Antiverse?

Antiverse is an artificial intelligence-driven techbio company that specialises in antibody design against difficult-to-drug targets, including G-protein coupled receptors (GPCRs) and ion channels. Headquartered in Cardiff, UK and with offices in Boston, MA, Antiverse combines state-of-the-art machine learning techniques and advanced cell line engineering to develop de novo antibody therapeutics. With a main focus on establishing long-term partnerships, Antiverse has collaborated with two top 20 global pharmaceutical companies. In addition, they are developing a strong internal pipeline of antibodies against several challenging drug targets across various indications.

For more information, please visit ⁠https://www.antiverse.io⁠

Never miss a future event!

We'll notify you when there's a new event scheduled. Fill out ⁠⁠this form⁠⁠ to sign up for marketing communications from Antiverse. We post about upcoming events on LinkedIn and Twitter.

LinkedIn: ⁠⁠https://www.linkedin.com/company/antiverse/⁠⁠

X: ⁠⁠https://twitter.com/AntiverseHQ⁠